NEA Diagnostics
Certificate of analysis
2026-884HLTNC2
Tesamorelin - 20mg
Tested for: IQON
Reported 5/20/2026
PASS
Purity
99.43%
Label claim
20 mg
Measured
19.88 mg
Of label
99.4%
COA #
2026-884HLTNC2
Lot number
5644
Accession
884HLTNC2
Labeled content
20 mg
Purity
99.43%
Net peptide content
19.88 mg
Appearance
White Lyophilized Powder
Received date
5/7/2026
Reported date
5/20/2026
Mass identificationPurityNet peptide content
Tesamorelin99.43%19.88 mg
Identity confirmation
Status
✓ Confirmed
Expected mass
5135.9 Da
Observed mass
5135.9 Da
Mass spectrometry
Electrospray ionization confirms the target mass.
[M+2H]2+
2568.96 m/z
[M+H]+
5136.91 m/z
HPLC chromatogram
LC-MS/MS purity, reverse phase HPLC with UV at 214 nm
PeakRT (min)Area %
Solvent front3.60.2
Tesamorelin main peak6.899.43
Related impurity7.30.37
Heavy Metal Analysis (ICP-MS)
TestSpecificationResultsStatus
Arsenic (As)NMT 1.5 ppmNot detectedPASS
Cadmium (Cd)NMT 0.5 ppmNot detectedPASS
Chromium (Cr)NMT 10 ppmNot detectedPASS
Mercury (Hg)NMT 1.5 ppmNot detectedPASS
Lead (Pb)NMT 1 ppmNot detectedPASS
Sterility Testing (PCR)
TestSpecificationResultsStatus
Sterility (PCR)No GrowthNo GrowthPASS
Endotoxin Testing (USP <85>)
TestSpecificationResultsStatus
Endotoxin (USP <85>)NMT 0.05 EU/mL< 0.05 EU/mLPASS
About this result: contamination is reported as a quantitative value. Acceptable limits vary by product type and dose route; no unversioned threshold applies to RUO products. This result is below commonly referenced endotoxin thresholds.
Instrument: Agilent 1260 Infinity II with 6120 single quad MS
Laboratory: NEA Diagnostics, San Diego, CA
This page is the authoritative version of certificate 2026-884HLTNC2. Any PDF copy should match it exactly. For research use only.
Searchable via labneadiagnostics.comCOA # 2026-884HLTNC2 · Issued 5/20/2026